Announcements about corrections in usage, quality and relevant information

We announce the recently discovered incident regarding use, quality and relevant information of our bioresource. We have informed directly the users who have received the resource about the incident.

Date Name of a resource concerned Incident Measures taken
July 26, 2023 RCB1981 HD-Mar2 (Hodgkin lymphoma cell line)
RCB1435 KE-97 (Stomach cancer cell line)
Derived cell type is different from the registered information of the depositor, respectively. (reference) HD-Mar2 is distributed with the corrected characteristic information.
Distribution of KE-97 was stopped.
July 26, 2023 RCB2712 MAEC (Mouse cell line)
RCB0752 TKD2 (Mouse cell line)
RCB2818 B1203L (Lung cancer cell line)
There was an error in the characteristic information created in the cell bank, respectively. (reference) All three cell lines are distributed with the corrected characteristic information.
August 1, 2019 RCB1293 SSP-25 (Human intrahepatic cholangiocarcinoma) Different from the cell line described in the original paper. (reference) Continue distribution with the precise information
October 24, 2018 RCB1156 Hepa-T1 (a cell line derived from Tilapia)
RCB0281 FRI-SpIm-1229 (a cell line derived from Lemyra imparilis)
RCB1733 LAH1 (a cell line derived from Pelophylax nigromaculatus)
RCB1735 LAH2 (a cell line derived from Pelophylax nigromaculatus)
Derived from a different species. (reference) Stop distribution of these 4 cell lines
March 12, 2015 RCB0179 23CLN (Bovine-derived cell line) Derived from porcine but not bovine.(reference) Stop provision of 23CLN for the moment
March 26, 2014 RCB2087 AZ521(Stomach cancer cell line) Misidentification of HuTu80 (Duodenal cancer cell line) in ATCC. (reference) There is no authentic stock of AZ521 and stop provision of AZ521
January 21, 2014 RCB1982 MOLT-17(Leukemia cell line) Misidentification of an unknown cell line. (reference) Replaced with RCB4561 MOLT-17 obtained from DSMZ

Comments are closed.